April 30, 2021
Inducible suppressive T-cell JB-101, which we are developing with Juntendo University, has been designated as an item subject to the Ministry of Health, Labour and Welfare’s “Pioneer Review Designation System”.
April 30, 2021
Inducible suppressive T-cell JB-101, which we are developing with Juntendo University, has been designated as an item subject to the Ministry of Health, Labour and Welfare’s “Pioneer Review Designation System”.
September 4, 2020
An investigator-initiated clinical study was started with collaborative researchers at Juntendo University.
